Atlas Trials

FLOR3 Gene Polymorphism in Predicting Outcomes of Tyrosine Kinase Inhibitor(TKI)Stopping in Chronic Myeloid Leukemia

Clinical trial NCT05152537 · UNKNOWN

Trial details

NCT number
NCT05152537
Sponsor
Affiliated Hospital of Nantong University
Status
UNKNOWN
Study type
OBSERVATIONAL
FolateCMLTreatment-free Remission
Start date
2021-01-01
Primary completion
2023-06-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.